Allied Minds has returned to back satellite intelligence gathering technology company HawkEye 360 after having taken part in an $11m round in 2016.

American Express Ventures participated in the round's first tranche earlier this year, and Even Financial has now raised a total of $25m.

Eli Lilly, AbbVie, Pfizer, Johnson & Johnson and WuXi AppTec have all backed neurological disorder drug developer Magnolia Neurosciences at launch.

Antibiotics developer Bugworks Research has been backed by Utec in its bid to commercialise a treatment for hospital superbugs.

Based on research at MD Anderson, Magnolia Neurosciences has launched with funding from corporates AbbVie, Eli Lilly, Pfizer, Johnson & Johnson and WuXi AppTec.

Fresh produce distributor Wangjiahuan has raised $58.5m from Global Logistic Properties subsidiary Hidden Hill Modern Logistics Private Equity Fund.

Takeda invested $20m in the round and is providing $80m in development financing through a strategic partnership deal.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

The AI testing data platform secured $11.8m in an Evolution Equity Partners-led round that included Mastercard, EDP, Sony and Amazon Alexa Fund.